Standard Biotools (LAB) Change in Account Payables (2010 - 2026)
Standard Biotools (LAB) posted quarterly Change in Account Payables of -$1.2 million for Q1 2026, down 111.76% year-over-year from $10.4 million in Q1 2025, and down 287.44% quarter-over-quarter from $653000.0 in Q4 2025.
Standard Biotools (LAB) Change in Account Payables (2010 - 2026) Analysis & Trends
Standard Biotools (LAB) has reported Change in Account Payables for 17 consecutive years, with -$1.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Account Payables fell 111.76% year-over-year to -$1.2 million; the TTM figure through Mar 2026 stood at $1.8 million (up 154.79% YoY), while the FY2025 annual figure was $2.4 million, up 118.78% from the prior year.
- Change in Account Payables slipped to -$1.2 million in Q1 2026 per LAB's latest filing, from $653000.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $2.1 million in Q4 2023 and bottomed at -$10.3 million in Q1 2024.
- Historically, Change in Account Payables has averaged -$760000.0 across 5 years, with a median of -$88000.0 in 2024.
- Annual changes were most pronounced in 2024 — Change in Account Payables plunged 772.13% — and 2025, when it jumped 842.05%.
- Standard Biotools' Change in Account Payables stood at -$1.3 million in 2022, then surged by 264.86% to $2.1 million in 2023, then sank by 104.19% to -$88000.0 in 2024, then surged by 842.05% to $653000.0 in 2025, then plunged by 287.44% to -$1.2 million in 2026.
- Business Quant data shows LAB's Change in Account Payables at -$1.2 million in Q1 2026, $653000.0 in Q4 2025, and $946000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | - |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 71.00 Mn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | - |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | -200.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | - |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 4.30 Mn |
| 10 | Standard Biotools | 260.01 Mn | -216.70 Mn | 10.54 Mn | 1.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.67 Mn |
| Jun 30, 2026 | 1.67 Mn |
| Mar 31, 2026 | -1.22 Mn |
| Mar 31, 2026 | -1.22 Mn |
| Dec 31, 2025 | 653,000.00 |
| Dec 31, 2025 | 653,000.00 |
| Sep 30, 2025 | 946,000.00 |
| Sep 30, 2025 | 946,000.00 |
| Jun 30, 2025 | 1.42 Mn |
| Jun 30, 2025 | 1.42 Mn |
| Mar 31, 2025 | -578,000.00 |
| Mar 31, 2025 | -578,000.00 |
| Dec 31, 2024 | -88,000.00 |
| Dec 31, 2024 | -88,000.00 |
| Sep 30, 2024 | -2.19 Mn |
| Sep 30, 2024 | -2.19 Mn |
| Jun 30, 2024 | -410,000.00 |
| Jun 30, 2024 | -410,000.00 |
| Mar 31, 2024 | -10.28 Mn |
| Mar 31, 2024 | -10.28 Mn |